NUT Carcinoma, from the CureRays guide library.

NUT carcinoma is a rare, fast-growing cancer defined by a single gene change (a NUTM1 fusion) that most often starts in the chest or the head and neck, and is treated with a combination of surgery, radiation, and chemotherapy alongside newer targeted drugs being tested in trials.

What it is.

NUT carcinoma (also called NUT midline carcinoma) is a rare and aggressive cancer that is defined not by where it starts but by a specific genetic change inside the tumor cells. In these cancers, a gene called NUTM1 becomes abnormally fused to a partner gene — most often BRD4. This single fusion drives the cancer to grow quickly and keeps its cells in an immature, rapidly dividing state. NUT carcinoma can arise anywhere but most commonly appears along the midline of the body: the chest (around the lungs and the space between them), the head and neck, and the sinuses. Because it is rare and can look like other 'poorly differentiated' cancers under the microscope, it is often missed unless a pathologist specifically tests for the NUT protein. Confirming the diagnosis matters, because it explains the aggressive behavior and opens the door to clinical trials of drugs aimed directly at the fusion.

How radiation treats it.

Radiation damages the DNA inside cancer cells so they can no longer divide and grow. NUT carcinoma cells divide very quickly, which can make them sensitive to radiation, so high-dose radiation is an important part of controlling the disease where it started — after surgery, in place of surgery when the tumor can't be removed, and to relieve symptoms such as pain or breathing problems in advanced disease. Modern techniques like intensity-modulated radiation and, for head-and-neck tumors, proton therapy shape the dose tightly around the cancer while protecting nearby organs. Radiation is painless during delivery, given over a series of daily sessions, and external-beam radiation leaves no radioactivity in the body. Because NUT carcinoma is aggressive, radiation is almost always combined with chemotherapy and, when possible, surgery rather than used alone.

The ways we can treat it.

Intensity-modulated radiation (IMRT). Beams are shaped precisely around the tumor to deliver a high dose while sparing nearby vital structures such as the lungs, heart, eyes, optic nerves, and brain, depending on the site.

Proton therapy (selected sites). For sinus and head-and-neck tumors near the eyes and brain, protons can reduce dose to those sensitive structures and lower side effects.

Concurrent chemoradiation. Radiation and chemotherapy are given together so the chemotherapy makes the cancer cells more sensitive to radiation while also treating disease elsewhere in the body.

Questions we hear often.

Why is testing for the NUT protein so important? NUT carcinoma can look like many other 'poorly differentiated' cancers under the microscope, so it is often missed unless the pathologist specifically tests for the NUT protein. Confirming the diagnosis explains the aggressive behavior, prevents misdiagnosis, and — critically — opens the door to clinical trials of drugs that target the fusion directly.

Is there a standard treatment? There is no single standard protocol because NUT carcinoma is so rare. The best approach is aggressive, coordinated care that often combines surgery (when possible), radiation, and chemotherapy, started quickly, with strong encouragement to join a clinical trial testing targeted drugs.

What are BET inhibitors? BET inhibitors are targeted drugs designed to block the very protein the NUTM1 fusion produces, which the cancer depends on to grow. Several are being tested in trials, and newer ones such as ZEN-3694 have received FDA designations to speed their study. They are not yet a routine approved treatment, which is why trial enrollment matters.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.